Immunoprofiling in Neuroendocrine Neoplasms: Implications for Immunotherapy

被引：0
作者：
Busse, A. [1 ]
Spenke, C. [2 ]
Arsenic, R. [3 ]
Briest, F. [2 ]
Sipos, B. [4 ]
Kaemmerer, D. [5 ]
Pavel, M. [6 ]
Mochmann, L. H. [1 ]
Baum, R. P. [7 ]
Wirtz, R. [8 ]
Hummel, M. [3 ]
Grabowski, P. [2 ]
机构：
[1] Charite Univ Med Berlin, Campus Benjamin Franklin, Berlin, Germany
[2] Charite Univ Med Berlin, Campus Virchow Klinikum, Berlin, Germany
[3] Charite Univ Med Berlin, Campus Mitte, Berlin, Germany
[4] Inst Pathol, Tubingen, Germany
[5] Dept Surg, Bad Berka, Germany
[6] Univ Erlangen Nurnberg, Med Clin 1, Erlangen, Germany
[7] Dept Nucl Med, Bad Berka, Germany
[8] Stratifier Co, Cologne, Germany
来源：
NEUROENDOCRINOLOGY | 2019年 / 108卷
关键词：
immunotherapy; nen; nec; checkpoint inhibitors; mdsc; immunosuppression;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A05
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [41] Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
    Pan, Wei-Xuan
    Zhang, Xin-Mu
    Hao, Shao-Long
    Han, Wei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (26) : 4174 - 4185
  • [42] Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
    Maggio, Ilaria
    Manuzzi, Lisa
    Lamberti, Giuseppe
    Ricci, Angela Dalia
    Tober, Nastassja
    Campana, Davide
    CANCERS, 2020, 12 (04)
  • [43] Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome
    Jasna Metovic
    Eliano Cascardi
    Silvia Uccella
    Roberta Maragliano
    Giulia Querzoli
    Simona Osella-Abate
    Alessandra Pittaro
    Stefano La Rosa
    Giuseppe Bogina
    Paola Cassoni
    Caterina Marchiò
    Anna Sapino
    Isabella Castellano
    Mauro Papotti
    Virchows Archiv, 2022, 481 : 839 - 846
  • [44] Sintilimab in Patients with Previously Treated Metastatic Neuroendocrine Neoplasms
    Jia, Ru
    Li, Yi
    Xu, Nong
    Jiang, Hai-Ping
    Zhao, Chuan-Hua
    Liu, Rong-Rui
    Shi, Yue
    Zhang, Yao-Yue
    Wang, Shu-Yan
    Zhou, Hui
    Xu, Jian-Ming
    ONCOLOGIST, 2022, 27 (08) : E625 - E632
  • [45] Immunotherapeutics at the spearhead: current status in targeting neuroendocrine neoplasms
    Anna Koumarianou
    Gregory A. Kaltsas
    Eleftherios Chatzellis
    Georgios Kyriakopoulos
    Denise Kolomodi
    Krystallenia I. Alexandraki
    Endocrine, 2021, 73 : 232 - 239
  • [46] Translational challenges in pancreatic neuroendocrine tumor immunotherapy
    Abu Egal, Erika Said
    Jacenik, Damian
    Soares, Heloisa Prado
    Beswick, Ellen J.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [47] Immunotherapy in neuroendocrine tumors Timing and target group
    Auernhammer, Christoph Josef
    Pavel, Marianne Ellen
    ONKOLOGIE, 2022, 28 (08): : 660 - 666
  • [48] The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond
    Sorbye, Halfdan
    Baudin, Eric
    Perren, Aurel
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (03) : 683 - +
  • [49] Updates in histopathological classification and tissue biomarkers of digestive neuroendocrine neoplasms: What the clinician should know
    Couvelard, Anne
    Cazes, Aurelie
    Cros, Jerome
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (05)
  • [50] Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives
    Zhang, Xian-Bin
    Fan, Yi-Bao
    Jing, Rui
    Getu, Mikiyas Amare
    Chen, Wan-Ying
    Zhang, Wei
    Dong, Hong-Xia
    Dakal, Tikam Chand
    Hayat, Akhtar
    Cai, Hua-Jun
    Ashrafizadeh, Milad
    Abd El-Aty, A. M.
    Hacimuftuoglu, Ahmet
    Liu, Peng
    Li, Tian-Feng
    Sethi, Gautam
    Ahn, Kwang Seok
    Ertas, Yavuz Nuri
    Chen, Min-Jiang
    Ji, Jian-Song
    Ma, Li
    Gong, Peng
    MILITARY MEDICAL RESEARCH, 2024, 11 (01)
12345